Leading the Way in Life Science Technologies

GEN Exclusives

More »

February 1, Vol. 25, No. 3

  • Feature Articles

    • Antibody Therapeutics Dominate Meeting
    • Recombinant antibody therapeutics are moving to a next generation of products, according to a keynote address by Ronald Levy, MD, given at IBC's recent meeting held in San Diego, "Antibody Engineering and Therapeutics"... more »
    • High Throughput Screening of GPCRs
    • Kathy Liszewski
    • More than 50% of all current drugs and nearly 25% of the top 200 best-selling drugs target G-protein-coupled receptors (GPCRs)These heterotrimeric proteins contain seven membrane-spanning segments and consist of α, β, and γ subunits... more »
    • Advances in Microgenomics: Less is More
    • Once considered a limitation, small cell samples have now led to new technology advances that are providing researchers with faster and more accurate molecular information These advances include separation methods to obtain pure cell populations, novel gene expression techniques, and ... more »
    • Atlanta Bioscience Breaks into the Top Ten
    • The Atlanta metropolitan region ranks third nationally for the number of Fortune 500 companies headquartered there Additionally, several medical organizations, such as the Centers for Disease Control and Prevention (CDC), the American Cancer Society, and the Arthritis Foundation are based ... more »
    • Re-Engineering the Drug Development Pipeline
    • Mary Addonizio
    • Fail fast, fail cheap is a common clich in drug development Studies project that anywhere from 4060% of potential drugs candidates fail in development due to absorption, distribution, metabolism, excretion, and toxicology (ADME-Tox) problems, and that per drug, companies allocate ... more »
    • Could London Become a Major Biotech Hub?
    • London's proximity to world-class universities providing high quality research and a thriving community of financial experts makes it an ideal place for biotech companies to locate, stated Jo Valentine, CEO of the business campaign group, London First, at the recent ... more »
  • Columns

    • The Impact of Biotech Licensing
    • Biotechnology companies at all stages of growth need a robust technology platform and capital StartUpCo, a hypothetical emerging biotech company, needs a technology platform and instant credibility to attract investors Typically, StartUpCo looks to an academic or biomedical research institution, ... more »